192 related articles for article (PubMed ID: 30858725)
1. Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.
Tremmel E; Hofmann S; Kuhn C; Heidegger H; Heublein S; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
Breast Cancer (Dove Med Press); 2019; 11():87-97. PubMed ID: 30858725
[TBL] [Abstract][Full Text] [Related]
2. TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC.
Stavrou S; Gratz M; Tremmel E; Kuhn C; Hofmann S; Heidegger H; Peryanova M; Hermelink K; Hutter S; Toth B; Mayr D; Mahner S; Jeschke U; Vattai A
Endocr Connect; 2018 Feb; 7(2):372-384. PubMed ID: 29472377
[TBL] [Abstract][Full Text] [Related]
3. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
4. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.
Bellusci L; Laurino A; Sabatini M; Sestito S; Lenzi P; Raimondi L; Rapposelli S; Biagioni F; Fornai F; Salvetti A; Rossi L; Zucchi R; Chiellini G
Front Pharmacol; 2017; 8():905. PubMed ID: 29311919
[TBL] [Abstract][Full Text] [Related]
5. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
6. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
[No Abstract] [Full Text] [Related]
7. Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.
Vattai A; Akyol E; Kuhn C; Hofmann S; Heidegger H; von Koch F; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Spitzweg C; Toth B; Mahner S; Jeschke U; Ditsch N
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1637-1647. PubMed ID: 28409272
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.
Cöster M; Biebermann H; Schöneberg T; Stäubert C
Eur Thyroid J; 2015 Sep; 4(Suppl 1):9-20. PubMed ID: 26601069
[TBL] [Abstract][Full Text] [Related]
9. Trace Amine-Associated Receptor 1 Localization at the Apical Plasma Membrane Domain of Fisher Rat Thyroid Epithelial Cells Is Confined to Cilia.
Szumska J; Qatato M; Rehders M; Führer D; Biebermann H; Grandy DK; Köhrle J; Brix K
Eur Thyroid J; 2015 Sep; 4(Suppl 1):30-41. PubMed ID: 26601071
[TBL] [Abstract][Full Text] [Related]
10. Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.
Zhang X; Mantas I; Alvarsson A; Yoshitake T; Shariatgorji M; Pereira M; Nilsson A; Kehr J; Andrén PE; Millan MJ; Chergui K; Svenningsson P
Front Pharmacol; 2018; 9():166. PubMed ID: 29545750
[TBL] [Abstract][Full Text] [Related]
11. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
Chiellini G; Bellusci L; Sabatini M; Zucchi R
Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
[TBL] [Abstract][Full Text] [Related]
12. L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of
Tremmel E; Kuhn C; Kaltofen T; Vilsmaier T; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334070
[TBL] [Abstract][Full Text] [Related]
13. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
[TBL] [Abstract][Full Text] [Related]
14. Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.
Vogelsang TLR; Vattai A; Schmoeckel E; Kaltofen T; Chelariu-Raicu A; Zheng M; Mahner S; Mayr D; Jeschke U; Trillsch F
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445181
[TBL] [Abstract][Full Text] [Related]
15. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
[TBL] [Abstract][Full Text] [Related]
16. Update on 3-iodothyronamine and its neurological and metabolic actions.
Zucchi R; Accorroni A; Chiellini G
Front Physiol; 2014; 5():402. PubMed ID: 25360120
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
[TBL] [Abstract][Full Text] [Related]
18. Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders.
Rutigliano G; Bräunig J; Del Grande C; Carnicelli V; Masci I; Merlino S; Kleinau G; Tessieri L; Pardossi S; Paisdzior S; Dell'Osso L; Biebermann H; Zucchi R
Front Pharmacol; 2019; 10():1027. PubMed ID: 31572197
[No Abstract] [Full Text] [Related]
19. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S
Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521
[TBL] [Abstract][Full Text] [Related]
20. The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling.
Dinter J; Khajavi N; Mühlhaus J; Wienchol CL; Cöster M; Hermsdorf T; Stäubert C; Köhrle J; Schöneberg T; Kleinau G; Mergler S; Biebermann H
Eur Thyroid J; 2015 Sep; 4(Suppl 1):21-9. PubMed ID: 26601070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
